Acquiring Company
XORTX Therapeutics
Acquired Company
Vectus Biosystems Limited
Calgary
AustraliaBiotechnologyHealth CareTherapeuticsPharmaceuticalPharmaceutical ManufacturingBiotechnologyHealth CareDescription
XORTX Therapeutics Inc. has completed the acquisition of Vectus Biosystems Limited's Renal Anti-Fibrotic Therapeutic Program as of April 13, 2026. The agreement included a cash finder’s fee of US$240,000. This strategic acquisition aims to enhance XORTX's capabilities in developing treatments for renal diseases. The transaction aligns with XORTX's focus on innovative therapeutic solutions.
Don't miss XORTX Therapeutics's next move
Get an email the moment XORTX Therapeutics makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Vectus Biosystems Limited?
Vectus Biosystems Limited was acquired by XORTX Therapeutics, based in Calgary. The deal was reported on August 28, 2026. XORTX Therapeutics Inc. is a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX Therapeutics is publicly traded (XRTX) and operates in Biotechnology.
When did XORTX Therapeutics acquire Vectus Biosystems Limited?
XORTX Therapeutics's acquisition of Vectus Biosystems Limited was reported on August 28, 2026. XORTX Therapeutics Inc. has completed the acquisition of Vectus Biosystems Limited's Renal Anti-Fibrotic Therapeutic Program as of April 13, 2026. The agreement included a cash finder’s fee of US$240,000. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Vectus Biosystems Limited do?
Vectus Biosystems Limited is an Australian Securities Exchange listed company. The firm focuses on developing therapeutic programs, including those targeting kidney diseases. It is privately held, operating in Biotechnology, and is based in Australia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.